Avenue Therapeutics Quote - ATXI

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.375

Bid

0.30

Offer

0.50

Volume

0.00 Day's Range 0.00

0.3521 52 Week Range 3.9313

Market Cap

1.194M

Previous Close

0.375

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

3,183,603

Dividend Yield

PE Ratio

-0.10

Earnings Per Share (EPS)

-3.66

Revenue

Net Profit

-11.65M

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.avenuetx.com

Headquarters

Dover, Delaware, USA

Founded

Avenue Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATXI. The last closing price for Avenue Therapeutics was US$0.38. Over the last year, Avenue Therapeutics shares have traded in a share price range of US$ 0.3521 to US$ 3.9313.

Avenue Therapeutics currently has 3,183,603 shares in issue. The market capitalisation of Avenue Therapeutics is US$1.19 million. Avenue Therapeutics has a price to earnings ratio (PE ratio) of -0.10.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.375	0.375	0.375	0	0	CS
4	0	0	0.375	0.375	0.375	0	0	CS
12	0	0	0.375	0.375	0.375	0	0	CS
26	-1.4036	-78.9160013494	1.7786	2.2289	0.3521	212262	1.72844729	CS
52	-3.015	-88.9380530973	3.39	3.9313	0.3521	126819	1.88407259	CS
156	-280.875	-99.8666666667	281.25	1248.75	0.3521	1372925	190.78949823	CS
260	-11924.625	-99.9968553459	11925	14130	0.3521	1167661	647.12488183	CS

ATXI - Frequently Asked Questions (FAQ)

What is the current Avenue Therapeutics share price?

The current share price of Avenue Therapeutics is US$ 0.375

How many Avenue Therapeutics shares are in issue?

Avenue Therapeutics has 3,183,603 shares in issue

What is the market cap of Avenue Therapeutics?

The market capitalisation of Avenue Therapeutics is USD 1.19M

What is the 1 year trading range for Avenue Therapeutics share price?

Avenue Therapeutics has traded in the range of US$ 0.3521 to US$ 3.9313 during the past year

What is the PE ratio of Avenue Therapeutics?

The price to earnings ratio of Avenue Therapeutics is -0.1

What is the reporting currency for Avenue Therapeutics?

Avenue Therapeutics reports financial results in USD

What is the latest annual profit for Avenue Therapeutics?

The latest annual profit of Avenue Therapeutics is USD -11.65M

What is the registered address of Avenue Therapeutics?

The registered address for Avenue Therapeutics is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901

What is the Avenue Therapeutics website address?

The website address for Avenue Therapeutics is www.avenuetx.com

Which industry sector does Avenue Therapeutics operate in?

Avenue Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RBNERobin Energy Ltd	US$ 13.85 (313.43%)	101.81M
OPOceanPal Inc	US$ 1.63 (125.45%)	80.28M
LGHLWLion Group Holding Ltd	US$ 0.0052 (116.67%)	6.87M
NEONNeonode Inc	US$ 16.83 (68.47%)	4.78M
ICONIcon Energy Corporation	US$ 2.90 (62.01%)	59.04M
SBETSharpLink Gaming Inc	US$ 9.2275 (-71.63%)	41.92M
AIHSSenmiao Technology Ltd	US$ 0.381 (-63.01%)	16.8M
CHSNChanson International Holding	US$ 0.22 (-60.00%)	15.15M
KWMK Wave Media Ltd	US$ 2.91 (-50.43%)	2.59M
JZXNJiuzi Holdings Inc	US$ 1.56 (-46.39%)	2.24M
HCTIHealthcare Triangle Inc	US$ 0.0201 (-33.00%)	856.89M
GNLNGreenlane Holdings Inc	US$ 0.0101 (-34.42%)	792.34M
CGBSCrown LNG Holdings Ltd	US$ 0.1104 (31.43%)	788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 12.655 (3.81%)	246.13M
NVDANVIDIA Corporation	US$ 141.97 (-2.09%)	180.81M